EVALUATION OF BIOENHANCING EFFECT OF PIPERINE AND ITS ANALOGS ON THE PHARMACOKINETICS OF VERAPAMIL
Abstract
A present study was undertaken to understand the impact of Piperine and some of its derivatives on the bioavailability of verapamil used in the treatment of cardiac disorders. On oral administration, it undergoes fast biotransformation resulting in its low bioavailability. Its bioavailability varies between 20 % and 35 %. Piperine (a well-known bioenhancer) has been reported to improve the bioavailability of a wide range of structurally and therapeutically varied medicines. Hence some derivatives of piperine were synthesized and evaluated for their bioenhancing effect on verapamil. The bioenhancing effect of piperine and synthesized derivatives was investigated and compared using a validated HPLC method as per the USFDA guidelines. The pharmacokinetic characteristics of verapamil alone and when combined with piperine and its synthetic analogs were also investigated. When administered to Wistar rats, it was discovered that the bioavailability of verapamil was 1.54 times higher when given with piperine and it was 2.42 times higher when given with morpholine derivative. The study undertaken indicates that some synthetic derivatives of piperine can be successfully used to enhance the bioavailability of verapamil to a considerable extent.
Keywords:
Verapamil, Piperine, Bioenhancer, HPLC, Validation, PharmacokineticDOI
https://doi.org/10.25004/IJPSDR.2023.150305References
McAllister Jr RG, Hamann SR, Piascik MT. Aspects of the clinical pharmacology of verapamil, a calcium-entry antagonist. Biopharm Drug Dispos. 1983; 4:203-211.
Weir MR. Calcium channel blockers: their pharmacologic and therapeutic role in hypertension. Am J Cardiovasc Drugs. 2007; 7:5-15.
Shah HS, Tojo K, Chien YW. Enhancement of in vitro skin permeation of verapamil. Drug Dev Ind Pharm. 1992; 18:1461-1476.
Carlo M, Domenico C. New Therapeutical Procedures of Peyronie’s Disease: Transfer Capacitive Resistive Energy in Association with Hydroelectrophoresis with Verapamil. IJPRAS. 2020, 9:16-23.
Piao YJ, Choi JS. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats. Arch Pharm Res. 2008; 31: 518-522.
Sultana N, Arayne MS, Waheed A. Method development of verapamil in presence of NSAIDs using RP-HPLC technique. Bull Korean Chem Soc. 2011; 32: 2274-2278.
Bright A, Devi TR, Gunasekaran S. Application of RP-HPLC and UV-visible spectroscopy for the estimation of atenolol and verapamil in tablets before and after the expiry period. Int J Chem Tech Res. 2010; 2:865-870.
Arayne MS, Mirza AZ, Sultana N. Simultaneous determination of gliquidone, pioglitazone hydrochloride, and verapamil in formulation and human serum by RP-HPLC. J Chromatogr Sci. 2011; 49:114-117.
Lau-Cam CA, Piemontese D. Simplified reversed-phase HPLC method with spectrophotometric detection for the assay of verapamil in rat plasma. J Pharm Biomed Anal. 1998; 16:1029-1035.
Lemke TL, Williams DA, Roche VF, et al. Foye’s Principles of Medicinal Chemistry, 6th edition, 2010, 759-763.
Thiel A, Buskens C, Woehrle T, et al. Black pepper constituent piperine: Genotoxicity studies in vitro and in vivo. Food Chem Toxicol. 2014; 66:350-357.
Badmaev V, Majeed M, Norkus EP. Piperine, an alkaloid derived from black pepper increases serum response of beta-carotene during 14-days of oral beta-carotene supplementation. Nutr Res. 1999; 19:381-388.
Shankaracharya NB, Jaganmohan Rao L, Pura Naik J, et al. Characterisation of chemical constituents of Indian long pepper (Piper longum L.). J. Food Sci Tech. 1997; 34:73-75.
Fugh-Berman A, Ernst E. Herb–drug interactions: review and assessment of report reliability. Br J Clin Pharmacol. 2001; 52:587-595.
Vijayakumar RS, Surya D, Nalini N. Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress. Redox Report. 2004; 9:105-110.
Bang JS, Oh DH, Choi HM, et al. Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther. 2009; 11:1-9.
Taqvi SI, Shah AJ, Gilani AH. Blood pressure lowering and vasomodulator effects of piperine. J Cardiovas Pharmacol. 2008; 52:452-458.
Sahu P, Chaurasiya A, Gajbhiye V. OA01. 20. Enhanced hepatoprotective activity of piperine loaded optimised chitosan microspheres. Anc Sci Life. 2012; 32: S20.
Atal N, Bedi KL. Bioenhancers: Revolutionary concept to market. J. Ayurveda Integr Med. 2010; 1:96.
Wadhwa S, Singhal S, Rawal S. Bioavailability enhancement by piperine: a review. Asian J Biomed Pharm Sci. 2014; 4:1.
Singh A, Deep A. Piperine: a bioenhancer. Int J Pharm Tech. 2011; 1:1-5.
Atal CK, Dubey RK, Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther. 1985; 23:258-262.
Preetinder KS, Bharat P, Dinesh K. Comparative evaluation of anti-depressant activity of glycyrrhizaglabra and pipernigrum combination with individual drugs effects and standard drug imipramine in Mice. IJPRAS. 2013; 2: 16-21.
Bhutani MK, Bishnoi M, Kulkarni SK. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav. 2009; 92:39-43.
Pattanaik S, Hota D, Prabhakar P. Effect of simultaneous administration of piperine on plasma concentration of carbamazepine. Phytother Res. 2009; 12:264-269.
Auti PR, Choudhary AS, Gabhe SY, et al. Bioanalytical method development, validation and its application in pharmacokinetic studies of verapamil in the presence of piperine in rats. Int J Pharm Res. 2018; 10: 118-123.
Patel RB, Modi IA, inventors; Cadila Laboratories Ltd, assignee. Compositions containing piperine. United States patent US 5,616,593.1997.
Singh A, Jain R, inventors; Panacea Biotec Ltd, assignee. Pharmaceutical compositions containing at least one NSAID having increased bioavailability. United States patent US 6,017,932. 2000.
Shankaracharya NB, Jaganmohan RL, Pura Naik J, et al. Characterisation of chemical constituents of Indian long pepper (Piper longum L.). J Food Sci Tech. 1997; 34:73-75.
Auti P, Gabhe S, Mahadik K. Bioanalytical method development and its application to pharmacokinetics studies on Simvastatin in the presence of piperine and two of its synthetic derivatives. Drug Dev Ind Pharm. 2019; 45:664-668.
Chavarria D, Silva T, Magalhães e Silva D, et al. Lessons from black pepper: piperine and derivatives thereof. Expert Opin Ther Pat. 2016;26:245-264.
Kesarwani K, Gupta R. Bioavailability enhancers of herbal origin: An overview. Asian Pac J Trop Biomed. 2013; 3:253-266.
Tarirai C, Viljoen AM, Hamman JH. Herb–drug pharmacokinetic interactions reviewed. Expert Opin Drug Metab Toxicol. 2010; 6:1515-1538.
Lala LG, D’Mello PM, Naik SR. Pharmacokinetic and pharmacodynamic studies on interaction of “Trikatu” with diclofenac sodium. J Ethnopharmacol. 2004; 91:277-280.
Srinivasan K. Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr. 2007; 47:735-748.
Derosa G, Maffioli P, Sahebkar A. Piperine and its role in chronic diseases. Anti-inflammatory nutraceuticals and chronic diseases. Adv Exp Med Biol. 2016; 928:173-184.
Shah HS, Tojo K, Chien YW. Enhancement of in vitro skin permeation of verapamil. Drug Dev Ind Pharm. 1992; 18:1461-1476.
El-Faham A, Funosas RS, Prohens R, et al. COMU: a safer and more effective replacement for benzotriazole-based uronium coupling reagents. Chem Eur J 2009; 15:9404-9416.
Montalbetti CA, Falque V. Amide bond formation and peptide coupling. Tetrahedron. 2005; 61:10827-10852.
Dar BA, Zaheer Z, Fatema S, Jadav S, Farooqui M. KF-Al2O3 catalyzed domino one-pot, three-component synthesis of 3,5-disubstituted-1,2,4-oxadiazoles under microwave-assisted solvent free conditions and their biological activity. IJPRAS. 2015; 4: 93-99.
Smolec J, DeSilva B, Smith W, Weiner R, Kelly M, Lee B, Khan M, Tacey R, Howard , Celniker A, Shah V, Bowsher R, Mire-Sluis A, Findlay J, Saltarelli M, Quarmby V, Lansky D, Dillard R, Ullmann M, Keller S, Karnes H. Bioanalytical method validation for macromolecules in support of pharmacokinetic studies. Pharm Res. 2005; 22:1425-1431.
Kulkarni P, Lohidasan S, Mahadik K. Bioanalytical method development for momordicinin and its application to long-term pharmacokinetics in diabetic rats. Drug Dev Ind Pharm. 2021; 47:1064-1071.
Kadian N, Raju KS, Rashid M, et al. Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry. J Pharm Biomed Ana. 2016; 126:83-97.
Published
Abstract Display: 492 
PDF Downloads: 572 
